Mark Stolper

Mark Stolper

Directeur Financier/CFO chez ICAD

Fortune : 4 M $ au 31/05/2026

54 ans
Health Services
Finance
Consumer Services

Profil

Mark D.
Stolper
was the founder of Broadstream Capital Partners LLC, founded in 1999, where the title held was Partner.
Current jobs include Director at Rotech Healthcare, Inc. since 2016; Director at Surgalign Spine Technologies, Inc. since 2017; Director at American Addiction Centers, Inc.; Director at Rotech Healthcare Holdings, Inc. since 2016; Independent Director at The Oncology Institute, Inc. starting 2026; Chief Financial Officer & Executive Vice President at RadNet, Inc. since 2004; and Chief Financial Officer at iCAD, Inc. starting 2025.
Former jobs include Chairman at CompuMed, Inc. from 2009 to 2014; Director at ALCO Stores, Inc. from 2014 to 2015; Director at Tix Corp.
from 2011 to 2013; Independent Director at Metropolitan Health Networks, Inc. from 2010 to 2012; Director at GenesisCare USA, Inc.; Independent Director at On Track Innovations Ltd. from 2012 to 2016; Director at Physiotherapy Associates, Inc. from 2013 to 2016; Director at 21st Century Oncology Holdings, Inc. from 2018 to 2020; Independent Director at Coherus Oncology, Inc. from 2021 to 2025; Director at Surgical Solutions LLC from 2015 to 2017; Lead Independent Director at Surgalign Holdings, Inc. from 2020 to 2023; Chief Financial Officer at Primedex Health Systems, Inc.; Member at Dillon & Associates, Inc.; Member at Saratoga Management Co. LLC; Member-Corporate Finance Group at Dillon, Read & Co., Inc.; Member at Read & Co. Utility Services Ltd.; Member at Goldman Sachs Realty Management LLC from 1995 to 1998; Member at Archon Capital Management LLC from 1995 to 1999; Partner at West Coast Capital from 2001 to 2004.
Education includes undergraduate degree from the University of Pennsylvania in 1993, graduate degree from the University of California, Los Angeles, and undergraduate degree from The Wharton School of the University of Pennsylvania.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/03/2026 66 754 ( 0,09 % ) 4 M $ 31/05/2026

Postes actifs de Mark Stolper

SociétésPosteDébut
RADNET, INC. Directeur Financier/CFO 01/07/2004
AMERICAN ADDICTION CENTERS INC Directeur/Membre du Conseil -
ICAD Directeur Financier/CFO 17/07/2025
THE ONCOLOGY INSTITUTE, INC. Directeur/Membre du Conseil 02/01/2026
Directeur/Membre du Conseil 01/04/2016
Directeur/Membre du Conseil 01/02/2016
Directeur/Membre du Conseil 01/03/2017

Anciens postes connus de Mark Stolper

SociétésPosteFin
COHERUS ONCOLOGY, INC. Directeur/Membre du Conseil 11/06/2025
SURGALIGN HOLDINGS, INC. Directeur/Membre du Conseil 02/10/2023
░░░░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Mark Stolper

Formation de Mark Stolper

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

70

Relations au 1er degré

30

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées30

Health Services

Retail Trade

Health Services

Consumer Services

Health Services

Health Services

Finance

Finance

Technology Services

Health Technology

Consumer Services

Technology Services

Finance

Finance

Consumer Services

Finance

Health Services

Finance

Finance

Health Services

Health Services

Health Technology

Health Services

West Coast Capital

Health Technology

Consumer Services

Health Services

Health Technology

Distribution Services

Health Services

  1. Bourse
  2. Insiders
  3. Mark Stolper
🔇